137 related articles for article (PubMed ID: 23547647)
1. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study.
Assayag J; Forget A; Kettani FZ; Beauchesne MF; Moisan J; Blais L
Can J Psychiatry; 2013 Apr; 58(4):233-9. PubMed ID: 23547647
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the adherence and persistence to inhaled corticosteroids among adult patients with public and private drug insurance plans.
Cyr MC; Beauchense MF; Lemiere C; Blais L
J Popul Ther Clin Pharmacol; 2013; 20(1):e26-41. PubMed ID: 23392860
[TBL] [Abstract][Full Text] [Related]
3. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
[TBL] [Abstract][Full Text] [Related]
4. Difference in drug cost between private and public drug plans in Quebec, Canada.
M C; A F; I C; M S; L B
BMC Health Serv Res; 2022 Feb; 22(1):200. PubMed ID: 35164750
[TBL] [Abstract][Full Text] [Related]
5. Impact of Patient Reimbursement Timing and Patient Out-of-Pocket Expenses on Medication Adherence in Patients Covered by Private Drug Insurance Plans.
Després F; Forget A; Kettani FZ; Blais L
J Manag Care Spec Pharm; 2016 May; 22(5):539-47. PubMed ID: 27123915
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
[TBL] [Abstract][Full Text] [Related]
7. Neighbourhood Material and Social Deprivation and Exposure to Antidepressant Drug Treatment: A Cohort Study Using Administrative Data.
Lauzier S; Kadachi H; Moisan J; Vanasse A; Lesage A; Fleury MJ; Grégoire JP
Can J Psychiatry; 2018 Oct; 63(10):701-711. PubMed ID: 29514506
[TBL] [Abstract][Full Text] [Related]
8. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
[TBL] [Abstract][Full Text] [Related]
9. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
10. Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data.
Lachaine J; Rinfret S; Merikle EP; Tarride JE
Am Heart J; 2006 Jul; 152(1):164-9. PubMed ID: 16824851
[TBL] [Abstract][Full Text] [Related]
11. New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy.
Blais L; Kettani FZ; Beauchesne MF; Lemière C; Perreault S; Forget A
Ann Pharmacother; 2011 Mar; 45(3):335-41. PubMed ID: 21386018
[TBL] [Abstract][Full Text] [Related]
12. Long-term etanercept retention patterns and factors associated with treatment discontinuation: a retrospective cohort study using Canadian claims-level data.
Khraishi M; Ivanovic J; Zhang Y; Millson B; Brabant MJ; Charland K; Woolcott J; Jones H
Clin Rheumatol; 2018 Sep; 37(9):2351-2360. PubMed ID: 29766376
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of Self-reported Prescribed Analgesic Medication Use: Linkage Between the Quebec Pain Registry and the Quebec Administrative Prescription Claims Databases.
Lacasse A; Ware MA; Bourgault P; Lanctôt H; Dorais M; Boulanger A; Cloutier C; Shir Y; Choinière M
Clin J Pain; 2016 Feb; 32(2):95-102. PubMed ID: 25924096
[TBL] [Abstract][Full Text] [Related]
14. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
[TBL] [Abstract][Full Text] [Related]
15. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.
Dragomir A; Côté R; White M; Lalonde L; Blais L; Bérard A; Perreault S
Value Health; 2010; 13(1):87-94. PubMed ID: 19695008
[TBL] [Abstract][Full Text] [Related]
16. Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.
Khemiri A; Kharitonova E; Zah V; Ruby J; Toumi M
Postgrad Med; 2014 Sep; 126(5):113-20. PubMed ID: 25295655
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and predictors of antidepressant use in a cohort of pregnant women.
Ramos E; Oraichi D; Rey E; Blais L; Bérard A
BJOG; 2007 Sep; 114(9):1055-64. PubMed ID: 17565615
[TBL] [Abstract][Full Text] [Related]
18. The risks and costs of multiple-generic substitution of topiramate.
Duh MS; Paradis PE; Latrémouille-Viau D; Greenberg PE; Lee SP; Durkin MB; Wan GJ; Rupnow MF; LeLorier J
Neurology; 2009 Jun; 72(24):2122-9. PubMed ID: 19528520
[TBL] [Abstract][Full Text] [Related]
19. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma.
Marceau C; Lemière C; Berbiche D; Perreault S; Blais L
J Allergy Clin Immunol; 2006 Sep; 118(3):574-81. PubMed ID: 16950273
[TBL] [Abstract][Full Text] [Related]
20. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
